Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort.

Jorge Enrique Rojas-Rivera Takehiro HasegawaGema Fernandez-JuarezManuel PragaYuko SarutaBeatriz Fernandez-Fernandez Alberto Ortiz Arduannull null

Published in: Clinical kidney journal (2024)

PMN displayed characteristic plasma and urine cytokine patterns that evolved over time as patients responded to therapy. Baseline urinary CXCL13 concentration could be a prognostic marker of response to TAC-RTX.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
clinical trial
mesenchymal stem cells
bone marrow